SCOPOLAMINE API MARKET ANALYSIS

Market Challenges And Opportunities

Global Scopolamine API Market: Restraint

The major factor that hinders growth of the global scopolamine API market includes side effects associated with scopolamine and misuse of scopolamine. Scopolamine may cause side effects such as dry mouth, sleepiness, urinary retention, agitation, dilated pupils, sore throat, drowsiness, dizziness, etc. Some side effects can be serious which include rash, redness, difficulty speaking, seizure, painful or difficulty urinating, stomach pain, nausea, vomiting, etc.

Increasing number of surgeries globally is expected to drive growth of the scopolamine API market

Scopolamine is used as a medication for treating postoperative nausea and vomiting. Thus the rising number of surgeries is expected to drive the market growth over the forecast period. For instance, according to the news provided by the Asiri Central’s Brain and Spine Centre, in March 2020, Colombo marked a significant milestone recently of having performed 10,000 neurosurgical procedures since it was established in June 2010. The hospital has treated an average of 1,000 patients per year over the past five years

Increasing product launch by key players in the market is expected to drive the market growth during the forecast period.

The key players in the market are adopting organic growth strategies such as product launch, which is expected to drive the market growth over the forecast period. For instance, in October 2019, Perrigo Company plc, an over-the-counter consumer goods and specialty pharmaceutical company, announced the relaunch of the AB-rated generic equivalent of Transderm Scop (scopolamine 1.5 mg), used to treat the symptoms of nausea or vomiting.